TY - JOUR
T1 - Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects
AU - McCaul, Mary E.
AU - Wand, Gary S.
AU - Eissenberg, Thomas
AU - Rohde, Charles A.
AU - Cheskin, Lawrence J.
N1 - Funding Information:
A portion of this work was presented at the 1997 meeting of the Research Society on Alcoholism. The study was supported by USPHS grant R01-AA09569 and Johns Hopkins Bayview Medical Center General Clinical Research Center grant M01-RR02719. The authors thank Joseph Bezold, Shing Lee, and John Yingling for their help in conducting this research and analyzing the data.
PY - 2000/5
Y1 - 2000/5
N2 - Preclinical studies support endogenous opioid system involvement in alcohol reinforcement and consumption; however, recent clinical trials and human laboratory studies have provided mixed findings of the effects of naltrexone (a non-selective opioid antagonist) on alcohol responses. This study used a within-subject design (n = 23) to investigate naltrexone effects (0, 50 and 100 mg qd) on subjective and psychomotor responses to alcohol (none, moderate, high) in heavy drinkers. Before alcohol administration, subjects reported decreased desire to drink alcohol when maintained on 50 mg compared with placebo naltrexone. Following alcohol administration, active naltrexone significantly increased subjective ratings of sedative, and unpleasant/sick effects and decreased ratings of liking, best effects and desire to drink. Naltrexone generally did not alter subjective or objective indicators of drunkenness. Finally, high doses of naltrexone and alcohol interacted to produce the greatest decreases in liking and best effects. Findings support the role of endogenous opioids as determinants of alcohol's effects and suggest that naltrexone may be particularly clinically useful in those treatment patients who continue to drink heavily. Copyright (C) 2000 American College of Neuropsychopharmacology.
AB - Preclinical studies support endogenous opioid system involvement in alcohol reinforcement and consumption; however, recent clinical trials and human laboratory studies have provided mixed findings of the effects of naltrexone (a non-selective opioid antagonist) on alcohol responses. This study used a within-subject design (n = 23) to investigate naltrexone effects (0, 50 and 100 mg qd) on subjective and psychomotor responses to alcohol (none, moderate, high) in heavy drinkers. Before alcohol administration, subjects reported decreased desire to drink alcohol when maintained on 50 mg compared with placebo naltrexone. Following alcohol administration, active naltrexone significantly increased subjective ratings of sedative, and unpleasant/sick effects and decreased ratings of liking, best effects and desire to drink. Naltrexone generally did not alter subjective or objective indicators of drunkenness. Finally, high doses of naltrexone and alcohol interacted to produce the greatest decreases in liking and best effects. Findings support the role of endogenous opioids as determinants of alcohol's effects and suggest that naltrexone may be particularly clinically useful in those treatment patients who continue to drink heavily. Copyright (C) 2000 American College of Neuropsychopharmacology.
KW - Alcoholism
KW - Naltrexone
KW - Opioid
KW - Psychomotor responses
KW - Subjective responses
UR - http://www.scopus.com/inward/record.url?scp=0034061429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034061429&partnerID=8YFLogxK
U2 - 10.1016/S0893-133X(99)00147-5
DO - 10.1016/S0893-133X(99)00147-5
M3 - Article
C2 - 10731623
AN - SCOPUS:0034061429
SN - 0893-133X
VL - 22
SP - 480
EP - 492
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 5
ER -